Research Article
Efficacy and Safety of a Dexamethasone Implant in Patients with Diabetic Macular Edema at Tertiary Centers in Korea
Table 2
Comparison of the retreatment rates by group analysis.
| Group analysis | Presence of retreatment (%) | value |
| Treatment naïve versus nonnaïve | 11/31 (35.5%) versus 81/155 (52.3%) | 0.088 | Pseudophakic versus phakic | 37/74 (50.0%) versus 55/112 (49.1%) | 0.905 | Vitrectomized versus nonvitrectomized | 14/31 (45.2%) versus 78/155 (50.3%) | 0.600 | Presence versus absence of SRF | 35/56 (62.5%) versus 57/130 (43.8%) | 0.020 | Diffuse versus focal DME | 88/159 (55.3%) versus 4/27 (14.8%) | <0.001 |
|
|
SRF, subretinal fluid; DME, diabetic macular edema. Chi square test.
|